View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | Spain |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2030-05-01 |
| Par Value | 100000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 1300.00 |
| Coupon | 7.125 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 1300.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Grifols SA corporate note has a 7.13% fixed rate coupon paid on a semi-annual basis. It was issued on December 19, 2024 with an issue size of 1300.00 million EUR and matures on May 01, 2030 with a last coupon date of November 01, 2029. |
Grifols SA, founded in 1940 and headquartered in Barcelona, Spain, is a global healthcare company dedicated to improving the health and well-being of people through the development of life-saving therapies. The company specializes in the collection and processing of human plasma and offers a range of products for the treatment of various medical conditions, particularly in the fields of hematology, immunology, and infectious diseases.